화학공학소재연구정보센터
검색결과 : 13건
No. Article
1 Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC
Kim DM, Kim MJ, Moon JH, Lee EY, Hong JK, Lee S, Koh DI, Ryu YS, Kim SM, Jung SA, Shin JS, Kim J, Park YS, Hong SW, Lee SH, Jung J, Park SS, Kim D, Kim EH, Jeong HR, Gong JH, Kim J, Kim SC, Yu H, Ki SY, Kim TW, Jin DH
Biochemical and Biophysical Research Communications, 527(1), 305, 2020
2 Erlotinib-silk fibroin nanoparticles in inhibiting tumor
Li H, Qiu H, Wang JM, Sun ZL
Polymer Bulletin, 77(8), 4325, 2020
3 Dual-responsive nanosystem for precise molecular subtyping and resistant reversal of EGFR targeted therapy
Zhang YY, Zhang L, Lin XW, Ke LJ, Li BF, Xu L, Lv TT, Li ZY, Chen HJ, Gao Y
Chemical Engineering Journal, 372, 483, 2019
4 A surface enhanced Raman scattering based colloid nanosensor for developing therapeutic drug monitoring
Litti L, Ramundo A, Biscaglia F, Toffoli G, Gobbo M, Meneghetti M
Journal of Colloid and Interface Science, 533, 621, 2019
5 Enhancing anti-cancer activity of erlotinib by antibody conjugated for nanofibrin - In vitro studies on lung adenocarcinoma cell lines
Vedakumari SW, Senthil R, Sekar S, Babu CS, Sastry TP
Materials Chemistry and Physics, 224, 328, 2019
6 Early emergence of de novo EGFR T790M gatekeeper mutations during erlotinib treatment in PC9 non-small cell lung cancer cells
Kim S, Park AKJ, Cho J
Biochemical and Biophysical Research Communications, 503(2), 710, 2018
7 Chronopharmacodynamics and mechanisms of antitumor effect induced by erlotinib in xenograft-bearing nude mice
Lin PP, An FM, Xu X, Zhao LY, Liu L, Liu N, Wang PP, Liu J, Wang L, Li MC
Biochemical and Biophysical Research Communications, 460(2), 362, 2015
8 Gene Mutation Analysis in EGFR Wild Type NSCLC Responsive to Erlotinib: Are There Features to Guide Patient Selection?
Ulivi P, Delmonte A, Chiadini E, Calistri D, Papi M, Mariotti M, Verlicchi A, Ragazzini A, Capelli L, Gamboni A, Puccetti M, Dubini A, Burgio MA, Casanova C, Crino L, Amadori D, Dazzi C
International Journal of Molecular Sciences, 16(1), 747, 2015
9 Simultaneous determination of erlotinib and metabolites in human urine using capillary electrophoresis
Rodriguez J, Castaneda G, Munoz L, Navarro D, Villa JC
Electrophoresis, 35(10), 1489, 2014
10 Adsorption and desorption of tyrosine kinase inhibitor erlotinib on gold nanoparticles
Lam ATN, Yoon J, Ganbold EO, Singh DK, Kim D, Cho KH, Son SJ, Choo J, Lee SY, Kim S, Joo SW
Journal of Colloid and Interface Science, 425, 96, 2014